HDAC9 and colorectal carcinoma: Basal and selumetinib-induced expression of c-FLIPL was downregulated in BRAF-mutant CRC by treatment with the pan-HDAC inhibitor vorinostat, leading to caspase-8-dependent apoptosis induction [Table 2].